Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$333M |
| 2 |
Alibaba
BABA
|
+$303M |
| 3 |
Pfizer
PFE
|
+$269M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
Eversource Energy
ES
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Growth ETF
VUG
|
+$780M |
| 2 |
Linde
LIN
|
+$623M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$515M |
| 4 |
S&P Global
SPGI
|
+$449M |
| 5 |
UnitedHealth
UNH
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.66% |
| 2 | Healthcare | 13.63% |
| 3 | Financials | 11.69% |
| 4 | Communication Services | 9.98% |
| 5 | Consumer Discretionary | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Aon
AON
$81.4B
| $128M | 0.08% |
614,019
-2,883
| -0.5% | -$571K |
|
|
TWTR
252
DELISTED
Twitter, Inc.
TWTR
| $126M | 0.08% |
3,924,427
+51,655
| +1% | +$1.7M |
|
253
Elevance Health
ELV
$83.7B
| $126M | 0.08% |
416,392
-329,975
| -44% | -$90.8M |
|
254
Boston Scientific
BSX
$68.5B
| $126M | 0.08% |
2,780,868
-391,185
| -12% | -$16.4M |
|
255
Weyerhaeuser
WY
$17.7B
| $126M | 0.08% |
4,158,401
+3,061,068
| +279% | +$88.8M |
|
256
Morgan Stanley
MS
$333B
| $125M | 0.08% |
2,440,681
-1,098,705
| -31% | -$52M |
|
257
Oneok
OKE
$55.9B
| $125M | 0.08% |
1,646,107
-179,133
| -10% | -$12.8M |
|
258
iShares MSCI EAFE ETF
EFA
$76.8B
| $124M | 0.08% |
1,792,281
+619,449
| +53% | +$41.8M |
|
259
D.R. Horton
DHI
$42.3B
| $124M | 0.08% |
2,350,347
+305,513
| +15% | +$16.3M |
|
260
Omega Healthcare
OHI
$15.4B
| $123M | 0.08% |
2,903,397
-742,440
| -20% | -$31.4M |
|
261
Marathon Petroleum
MPC
$89.3B
| $121M | 0.08% |
2,015,509
-1,666,045
| -45% | -$104M |
|
262
Valero Energy
VLO
$88.7B
| $121M | 0.08% |
1,293,311
-165,831
| -11% | -$15.7M |
|
263
TransUnion
TRU
$16.1B
| $121M | 0.08% |
1,413,373
-45,470
| -3% | -$3.79M |
|
264
Chipotle Mexican Grill
CMG
$43B
| $120M | 0.08% |
7,187,450
-3,023,850
| -30% | -$48.5M |
|
265
Intuitive Surgical
ISRG
$130B
| $120M | 0.08% |
608,508
-50,064
| -8% | -$9.37M |
|
266
iShares MSCI Japan ETF
EWJ
$21.3B
| $119M | 0.08% |
2,008,084
+279,563
| +16% | +$16.5M |
|
267
Alcon
ALC
$33.7B
| $118M | 0.08% |
2,083,524
-226,674
| -10% | -$13M |
|
268
Dollar General
DG
$27.8B
| $118M | 0.08% |
753,547
-195,546
| -21% | -$31M |
|
269
Blackrock
BLK
$170B
| $115M | 0.08% |
228,851
-20,221
| -8% | -$9.59M |
|
270
Elanco Animal Health
ELAN
$12.7B
| $115M | 0.07% |
3,899,671
+126,263
| +3% | +$3.43M |
|
271
Stryker
SYK
$133B
| $114M | 0.07% |
540,812
+70,294
| +15% | +$14.6M |
|
272
Kinder Morgan
KMI
$70.3B
| $111M | 0.07% |
5,265,473
+324,576
| +7% | +$6.57M |
|
273
Baxter International
BAX
$12.6B
| $111M | 0.07% |
1,332,289
-17,918
| -1% | -$1.48M |
|
274
Workday
WDAY
$39.4B
| $111M | 0.07% |
673,602
+78,839
| +13% | +$13.1M |
|
275
Agree Realty
ADC
$9.74B
| $110M | 0.07% |
1,569,323
+48,315
| +3% | +$3.56M |
|
Similar funds
Deutsche Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Deutsche Bank held 5,318 positions worth $153B, up 6.6% from $144B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Deutsche Bank withdrew a net $5.3B in Q4 2019, closing 262 positions and reducing 1,924 holdings. Its most notable exit was Celgene Corp, an estimated $273M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Deutsche Bank opened a new position in XP worth $32.9M.
- Deutsche Bank's largest Q4 2019 buy was XP: 853,950 shares worth $32.9M.
- Deutsche Bank added most to Johnson & Johnson in Q4 2019, an estimated $333M increase.
- Deutsche Bank's biggest Q4 2019 reduction was Vanguard Growth ETF, cutting an estimated $780M.
- Deutsche Bank fully exited Celgene Corp in Q4 2019, selling an estimated $273M.
- Deutsche Bank's ten largest holdings make up 17% of its $153B portfolio in Q4 2019.
- Deutsche Bank opened 407 new positions and closed 262 in Q4 2019.
- Deutsche Bank's portfolio value rose 6.6% quarter-over-quarter to $153B.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.